Effect of the micro-immunotherapy medicine 2LPARK(®) on rat primary dopaminergic neurons after 6-OHDA injury: oxidative stress and survival evaluation in an in vitro model of Parkinson’s disease

BACKGROUND: Parkinson’s disease (PD) is a neurodegenerative disease characterized by motor impairments and resulting from progressive degenerative loss of midbrain dopaminergic (DAergic) neurons in the substantia nigra. Although the main cause of the loss of DAergic neurons is still unknown, various...

Descripción completa

Detalles Bibliográficos
Autores principales: Lilli, Nicoletta L, Révy, Delphine, Robelet, Sandra, Lejeune, Béatrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635836/
https://www.ncbi.nlm.nih.gov/pubmed/31372089
http://dx.doi.org/10.2147/DNND.S202966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635836/
https://www.ncbi.nlm.nih.gov/pubmed/31372089
http://dx.doi.org/10.2147/DNND.S202966

Ejemplares similares